Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1996-11-4
pubmed:abstractText
The old paradigm states that the greater the stenosis, the greater the risk of cardiac events. Revascularization procedures are the only effective approach to improving prognosis associated with coronary artery disease. In contrast, on the basis of the new paradigm, the nature of the plaque determines the risk of acute cardiovascular events. Dangerous plaques have a lipid-rich core with surrounding inflammation and a thin friable overlying fibrous cap, but they usually appear innocuous on angiography. Effective risk factor modification stabilizes the dangerous plaques and is associated with prompt improvement in endothelial dysfunction and a substantial decrease in the risk of acute cardiovascular events and death.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0025-6196
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
957-65
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8820770-Adrenergic beta-Antagonists, pubmed-meshheading:8820770-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:8820770-Anticholesteremic Agents, pubmed-meshheading:8820770-Antioxidants, pubmed-meshheading:8820770-Coronary Angiography, pubmed-meshheading:8820770-Coronary Artery Disease, pubmed-meshheading:8820770-Endothelium, Vascular, pubmed-meshheading:8820770-Exercise Test, pubmed-meshheading:8820770-Humans, pubmed-meshheading:8820770-Hypercholesterolemia, pubmed-meshheading:8820770-Inflammation, pubmed-meshheading:8820770-Lovastatin, pubmed-meshheading:8820770-Platelet Aggregation Inhibitors, pubmed-meshheading:8820770-Prognosis, pubmed-meshheading:8820770-Randomized Controlled Trials as Topic, pubmed-meshheading:8820770-Risk Factors, pubmed-meshheading:8820770-Simvastatin
pubmed:year
1996
pubmed:articleTitle
The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis.
pubmed:affiliation
Mid America Heart Institute, Kansas City, Missouri, USA.
pubmed:publicationType
Journal Article, Review